FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2019737248> ?p ?o ?g. }

• W2019737248 endingPage "3554" @default.
• W2019737248 startingPage "3548" @default.
• W2019737248 abstract "Anthrax vaccine adsorbed (AVA) administered intramuscularly (IM) results in fewer adverse events (AEs) than subcutaneous (SQ) administration. Women experience more AEs than men. Antibody response, female hormones, race, and body mass index (BMI) may contribute to increased frequency of reported injection site AEs.We analyzed data from the CDC AVA human clinical trial. This double blind, randomized, placebo controlled trial enrolled 1563 participants and followed them through 8 injections (AVA or placebo) over a period of 42 months. For the trial's vaccinated cohort (n=1267), we used multivariable logistic regression to model the effects of study group (SQ or IM), sex, race, study site, BMI, age, and post-vaccination serum anti-PA IgG on occurrence of AEs of any severity grade. Also, in a women-only subset (n=227), we assessed effect of pre-vaccination serum progesterone level and menstrual phase on AEs.Participants who received SQ injections had significantly higher proportions of itching, redness, swelling, tenderness and warmth compared to the IM study group after adjusting for other risk factors. The proportions of redness, swelling, tenderness and warmth were all significantly lower in blacks vs. non-black participants. We found arm motion limitation, itching, pain, swelling and tenderness were more likely to occur in participants with the highest anti-PA IgG concentrations. In the SQ study group, redness and swelling were more common for obese participants compared to participants who were not overweight. Females had significantly higher proportions of all AEs compared to males. Menstrual phase was not associated with any AEs.Female and non-black participants had a higher proportion of AVA associated AEs and higher anti-PA IgG concentrations. Antibody responses to other vaccines may also vary by sex and race. Further studies may provide better understanding for higher proportions of AEs in women and non-black participants." @default.
• W2019737248 created "2016-06-24" @default.
• W2019737248 creator A5010296860 @default.
• W2019737248 creator A5014941193 @default.
• W2019737248 creator A5044718641 @default.
• W2019737248 creator A5053815857 @default.
• W2019737248 creator A5057546038 @default.
• W2019737248 creator A5061644557 @default.
• W2019737248 creator A5069169403 @default.
• W2019737248 creator A5075290208 @default.
• W2019737248 creator A5081646689 @default.
• W2019737248 creator A5086629871 @default.
• W2019737248 date "2014-06-01" @default.
• W2019737248 modified "2023-09-27" @default.
• W2019737248 title "Evaluation of sex, race, body mass index and pre-vaccination serum progesterone levels and post-vaccination serum anti-anthrax protective immunoglobulin G on injection site adverse events following anthrax vaccine adsorbed (AVA) in the CDC AVA human clinical trial" @default.
• W2019737248 cites W1486962214 @default.
• W2019737248 cites W1942616017 @default.
• W2019737248 cites W1970514298 @default.
• W2019737248 cites W1977773205 @default.
• W2019737248 cites W1984394516 @default.
• W2019737248 cites W1991696101 @default.
• W2019737248 cites W1993127086 @default.
• W2019737248 cites W1994676162 @default.
• W2019737248 cites W1996345364 @default.
• W2019737248 cites W2015061670 @default.
• W2019737248 cites W2015258298 @default.
• W2019737248 cites W2020484670 @default.
• W2019737248 cites W2030152471 @default.
• W2019737248 cites W2031202023 @default.
• W2019737248 cites W2032310151 @default.
• W2019737248 cites W2042861035 @default.
• W2019737248 cites W2047281459 @default.
• W2019737248 cites W2047820619 @default.
• W2019737248 cites W2054292719 @default.
• W2019737248 cites W2072601330 @default.
• W2019737248 cites W2082461885 @default.
• W2019737248 cites W2090427176 @default.
• W2019737248 cites W2093688935 @default.
• W2019737248 cites W2112861955 @default.
• W2019737248 cites W2113826680 @default.
• W2019737248 cites W2124101405 @default.
• W2019737248 cites W2128269295 @default.
• W2019737248 cites W2129746975 @default.
• W2019737248 cites W2131643987 @default.
• W2019737248 cites W2139017495 @default.
• W2019737248 cites W2144772777 @default.
• W2019737248 cites W2155920306 @default.
• W2019737248 cites W2164345297 @default.
• W2019737248 cites W2171973389 @default.
• W2019737248 cites W2429227814 @default.
• W2019737248 doi "https://doi.org/10.1016/j.vaccine.2014.04.025" @default.
• W2019737248 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5761064" @default.
• W2019737248 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24768633" @default.
• W2019737248 hasPublicationYear "2014" @default.
• W2019737248 type Work @default.
• W2019737248 sameAs 2019737248 @default.
• W2019737248 citedByCount "24" @default.
• W2019737248 countsByYear W20197372482014 @default.
• W2019737248 countsByYear W20197372482015 @default.
• W2019737248 countsByYear W20197372482016 @default.
• W2019737248 countsByYear W20197372482017 @default.
• W2019737248 countsByYear W20197372482018 @default.
• W2019737248 countsByYear W20197372482020 @default.
• W2019737248 countsByYear W20197372482021 @default.
• W2019737248 countsByYear W20197372482022 @default.
• W2019737248 countsByYear W20197372482023 @default.
• W2019737248 crossrefType "journal-article" @default.
• W2019737248 hasAuthorship W2019737248A5010296860 @default.
• W2019737248 hasAuthorship W2019737248A5014941193 @default.
• W2019737248 hasAuthorship W2019737248A5044718641 @default.
• W2019737248 hasAuthorship W2019737248A5053815857 @default.
• W2019737248 hasAuthorship W2019737248A5057546038 @default.
• W2019737248 hasAuthorship W2019737248A5061644557 @default.
• W2019737248 hasAuthorship W2019737248A5069169403 @default.
• W2019737248 hasAuthorship W2019737248A5075290208 @default.
• W2019737248 hasAuthorship W2019737248A5081646689 @default.
• W2019737248 hasAuthorship W2019737248A5086629871 @default.
• W2019737248 hasBestOaLocation W20197372482 @default.
• W2019737248 hasConcept C126322002 @default.
• W2019737248 hasConcept C142724271 @default.
• W2019737248 hasConcept C159654299 @default.
• W2019737248 hasConcept C167508917 @default.
• W2019737248 hasConcept C197934379 @default.
• W2019737248 hasConcept C203014093 @default.
• W2019737248 hasConcept C204787440 @default.
• W2019737248 hasConcept C22070199 @default.
• W2019737248 hasConcept C27081682 @default.
• W2019737248 hasConcept C2777289321 @default.
• W2019737248 hasConcept C2780221984 @default.
• W2019737248 hasConcept C2780801004 @default.
• W2019737248 hasConcept C71924100 @default.
• W2019737248 hasConcept C90924648 @default.
• W2019737248 hasConceptScore W2019737248C126322002 @default.
• W2019737248 hasConceptScore W2019737248C142724271 @default.
• W2019737248 hasConceptScore W2019737248C159654299 @default.
• W2019737248 hasConceptScore W2019737248C167508917 @default.
• W2019737248 hasConceptScore W2019737248C197934379 @default.
• W2019737248 hasConceptScore W2019737248C203014093 @default.

• next